Pharming Group NV Cash Flow Reinvestment Rate
Pharming Group NV cash flow reinvestment rate. Pharming Group NV (PHAR) has a Cash Flow Reinvestment Rate of 0.15x as of March 2026, reinvesting $238.86K (capex $238.86K ) from operating cash flow of $1.63 Million. Explore PHAR operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Pharming Group NV (2017–2025)
Cash flow reinvestment rate of Pharming Group NV from 2017 to 2025. Historical reinvestment intensity for Pharming Group NV across 7 annual periods. Explore PHAR capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Pharming Group NV Cash Flow Reinvestment Rate by Year (2017–2025)
Pharming Group NV cash flow reinvestment rate by year from 2017 to 2025. Year-by-year capital reinvestment analysis for Pharming Group NV. For the full cash flow conversion analysis, see PHAR cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.72x | $85.97 Million | $50.07 Million | $751.09K | ▲ +428.3% |
| 2022 | 0.33x | $7.30 Million | $22.46 Million | $1.98 Million | ▼ -40.2% |
| 2021 | 0.54x | $20.59 Million | $37.84 Million | $16.72 Million | ▲ +191.8% |
| 2020 | 0.19x | $15.59 Million | $83.63 Million | $15.30 Million | ▼ -50.6% |
| 2019 | 0.38x | $27.95 Million | $74.15 Million | $25.45 Million | ▲ +155.5% |
| 2018 | 0.15x | $6.81 Million | $46.19 Million | $4.31 Million | ▼ -30.7% |
| 2017 | 0.21x | $9.76 Million | $45.84 Million | $7.25 Million | — |